Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORION-2: Inclisiran in Homozygous Familial Hypercholesterolemia Pilot
NCT02963311Phase 2Completed
- Sponsor
- The Medicines Company
- Start
- Dec 2016
- Primary completion
- Oct 2018
- Modality
- Antisense DNA, Conjugated siRNA, MicroRNA (miRNA)
- Countries
- 3
01
Overview
A Phase 2 trial of inclisiran in homozygous familial hypercholesterolemia (HoFH), sponsored by The Medicines Company. Started Dec 2016; status: completed.
02
Drugs
inclisiran
03
Conditions
homozygous familial hypercholesterolemia (HoFH)
Beyond the preview
Go deeper on NCT02963311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02963311.